WPD Pharmaceuticals Inc (WBIO)

0.0450
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0400/0.0450
  • Day's Range:
    0.0450 - 0.0450
  • Type:Equity
  • Market:Canada
  • ISIN:CA92941F1053
  • CUSIP:92941F105

WBIO Overview

Prev. Close
0.045
Day's Range
0.045-0.045
Revenue
-
Open
0.045
52 wk Range
0.03-0.24
EPS
-0.04
Volume
0
Market Cap
5.1M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
14,369
P/E Ratio
-
Beta
-
1-Year Change
-78.57%
Shares Outstanding
113,438,244
Next Earnings Date
-
What is your sentiment on WPD Pharma?
or
Market is currently closed. Voting is open during market hours.

WPD Pharmaceuticals Inc News

WPD Pharmaceuticals Inc Company Profile

WPD Pharmaceuticals Inc Company Profile

Employees
19
Market
Canada

WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company’s drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell